No abstract available
MeSH terms
-
Adipose Tissue / metabolism
-
Adipose Tissue / physiopathology
-
Antihypertensive Agents / pharmacology
-
Appetite / physiology
-
Body Weight / drug effects
-
C-Reactive Protein / analysis
-
Cannabinoid Receptor Modulators / physiology
-
Cardiovascular Diseases / blood
-
Cardiovascular Diseases / epidemiology*
-
Cardiovascular Diseases / prevention & control
-
Cardiovascular Diseases / therapy
-
Cholesterol, HDL / blood
-
Diabetes Mellitus / epidemiology
-
Diabetes Mellitus / metabolism
-
Humans
-
Hypoglycemic Agents / pharmacology
-
Life Style
-
Metabolic Syndrome / blood
-
Metabolic Syndrome / epidemiology*
-
Metabolic Syndrome / prevention & control
-
Metabolic Syndrome / therapy
-
Obesity / blood
-
Obesity / physiopathology
-
Physician Assistants
-
Piperidines / therapeutic use
-
Pyrazoles / therapeutic use
-
Receptor, Cannabinoid, CB1 / antagonists & inhibitors
-
Receptor, Cannabinoid, CB1 / physiology
-
Rimonabant
-
Risk Assessment
-
Risk Factors
-
Weight Gain / drug effects
Substances
-
Antihypertensive Agents
-
Cannabinoid Receptor Modulators
-
Cholesterol, HDL
-
Hypoglycemic Agents
-
Piperidines
-
Pyrazoles
-
Receptor, Cannabinoid, CB1
-
C-Reactive Protein
-
Rimonabant